100 ML linezolid 2 MG/ML Injection [Zyvox]
- RxCUI
- 1662280
- RxNorm name
- 100 ML linezolid 2 MG/ML Injection [Zyvox]
- Display name
- 100 ML linezolid 2 MG/ML Injection [Zyvox]
- Full name
- 100 ML linezolid 2 MG/ML Injection [Zyvox]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zyvox | LINEZOLID | Pharmacia & Upjohn Company LLC | 6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | 2026-06-23 | Warnings, Adverse reactions | 1662280 |
| Zyvox | LINEZOLID | Hp Halden Pharma AS | ce57225b-4580-442b-8c48-8045297cbb50 | 2024-05-28 | Warnings, Adverse reactions | 1662280 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 6e70e63b-bfd5-478d-a8ee-8ba22c9efabd | ZYVOX 200 MG in 100 ML Injection [PSN] · 100 ML linezolid 2 MG/ML Injection [Zyvox] [SBD] · 100 ML Zyvox 2 MG/ML Injection [SY] · Zyvox 200 MG per 100 ML Injection [SY] | 4 | 69 | These highlights do not include all the information needed to use ZYVOX safely and effectively. See full prescribing information for ZYVOX. ZYVOX ® (linezolid) injection, for intravenous use ZYVOX ® (linezolid) tablets, for oral use ZYVOX ® (linezolid) for oral suspension Initial U.S. Approval: 2000 | 20260519 |
| ce57225b-4580-442b-8c48-8045297cbb50 | ZYVOX 200 MG in 100 ML Injection [PSN] · 100 ML linezolid 2 MG/ML Injection [Zyvox] [SBD] · 100 ML Zyvox 2 MG/ML Injection [SY] · Zyvox 200 MG per 100 ML Injection [SY] | 4 | 4 | These highlights do not include all the information needed to use ZYVOX safely and effectively. See full prescribing information for ZYVOX. ZYVOX ® (linezolid) injection, tablets and oral suspension Initial U.S. Approval: 2000 | 20240528 |